Steven Cohen's EW Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 732,058 shares of Edwards Lifesciences Corporation (EW) worth $56.93 M, representing 0.10% of the portfolio. First purchased in 2014-Q3, this long-term strategic position has been held for 39 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in EW, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2024, adding 2.97 M shares. Largest reduction occurred in Q2 2024, reducing 2.53 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Edwards Lifesciences Corporation (EW) Holding Value Over Time
Track share changes against reported price movement
Quarterly Edwards Lifesciences Corporation (EW) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2014 | +1.24 M | New Buy | 1.24 M | $17.03 |
| Q4 2014 | -1.24 M | Sold Out | 0 | $0.00 |
| Q1 2015 | +1.44 M | New Buy | 1.44 M | $23.74 |
| Q2 2015 | -397,200 | Reduce 27.65% | 1.04 M | $23.74 |
| Q3 2015 | +360,000 | Add 34.64% | 1.4 M | $23.69 |
| Q4 2015 | -949,800 | Reduce 67.88% | 449,400 | $26.33 |
| Q1 2016 | -408,300 | Reduce 90.85% | 41,100 | $29.39 |
| Q2 2016 | +541,500 | Add 1317.52% | 582,600 | $33.24 |
| Q3 2016 | +431,100 | Add 74.00% | 1.01 M | $40.19 |
| Q4 2016 | +415,500 | Add 40.99% | 1.43 M | $31.23 |
| Q1 2017 | -1.09 M | Reduce 76.26% | 339,225 | $31.36 |
| Q2 2017 | +999,975 | Add 294.78% | 1.34 M | $39.41 |
| Q3 2017 | +84,285 | Add 6.29% | 1.42 M | $36.44 |
| Q4 2017 | -1.03 M | Reduce 72.60% | 390,000 | $37.57 |
| Q1 2018 | +210,000 | Add 53.85% | 600,000 | $46.51 |
| Q2 2018 | -600,000 | Sold Out | 0 | $0.00 |
| Q3 2018 | +13,800 | New Buy | 13,800 | $58.04 |
| Q4 2018 | +184,800 | Add 1339.13% | 198,600 | $51.06 |
| Q1 2019 | -33,540 | Reduce 16.89% | 165,060 | $63.78 |
| Q2 2019 | -130,857 | Reduce 79.28% | 34,203 | $61.57 |
| Q3 2019 | +120,120 | Add 351.20% | 154,323 | $73.30 |
| Q4 2019 | -75,888 | Reduce 49.17% | 78,435 | $77.76 |
| Q1 2020 | +164,112 | Add 209.23% | 242,547 | $62.87 |
| Q2 2020 | +244,137 | Add 100.66% | 486,684 | $69.11 |
| Q3 2020 | -367,269 | Reduce 75.46% | 119,415 | $79.82 |
| Q4 2020 | -119,415 | Sold Out | 0 | $0.00 |
| Q1 2021 | +579,142 | New Buy | 579,142 | $83.64 |
| Q2 2021 | -579,142 | Sold Out | 0 | $0.00 |
| Q1 2023 | +385 | New Buy | 385 | $82.68 |
| Q2 2023 | -385 | Sold Out | 0 | $0.00 |
| Q3 2023 | +22,199 | New Buy | 22,199 | $69.28 |
| Q4 2023 | -22,199 | Sold Out | 0 | $0.00 |
| Q1 2024 | +2.97 M | New Buy | 2.97 M | $95.56 |
| Q2 2024 | -2.53 M | Reduce 85.05% | 444,162 | $92.37 |
| Q3 2024 | -444,162 | Sold Out | 0 | $0.00 |
| Q4 2024 | +588,206 | New Buy | 588,206 | $74.03 |
| Q1 2025 | +880,527 | Add 149.70% | 1.47 M | $72.48 |
| Q2 2025 | +1.57 M | Add 106.94% | 3.04 M | $78.21 |
| Q3 2025 | -2.31 M | Reduce 75.91% | 732,058 | $77.77 |
Steven Cohen's Edwards Lifesciences Corporation Investment FAQs
Steven Cohen first purchased Edwards Lifesciences Corporation (EW) in Q3 2014, acquiring 1,237,800 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Edwards Lifesciences Corporation (EW) for 39 quarters since Q3 2014.
Steven Cohen's largest addition to Edwards Lifesciences Corporation (EW) was in Q1 2024, adding 2,970,804 shares worth $283.89 M.
According to the latest 13F filing for Q3 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 732,058 shares of Edwards Lifesciences Corporation (EW), valued at approximately $56.93 M.
As of the Q3 2025 filing, Edwards Lifesciences Corporation (EW) represents approximately 0.10% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Edwards Lifesciences Corporation (EW) was 3,039,381 shares, as reported at the end of Q2 2025.